Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL FINE

NPI
1346670007
CMS profile
242368
Location
LAGUNA BEACH, CA

General Payments · PY2018–2024

$407,981.09

  • Reported across 354 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$33,275.97

24 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $11,500.00 4
Boehringer Ingelheim Pharmaceuticals, Inc. $6,488.02 9
CHIESI USA, INC. $3,000.00 1
GENZYME CORPORATION $2,542.50 2
BioMarin Pharmaceutical Inc. $2,314.95 3
Incyte Corporation $2,227.50 1
SANOFI PASTEUR INC. $1,578.00 1
PFIZER INC. $1,350.00 1
Gilead Sciences, Inc. $1,180.00 1
Johnson & Johnson Health Care Systems Inc. $1,095.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $87,083.99 107
PY2019 $85,096.39 106
PY2020 $31,360.50 15
PY2021 $67,317.17 37
PY2022 $70,840.50 46
PY2023 $33,006.57 19
PY2024 $33,275.97 24

Payment records · PY2024 (24)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $3,500.00 05/21/2024 Consulting Fee Undisputed 01/23/2026 1117553469 CMS
Amgen Inc. $2,500.00 05/21/2024 Travel and Lodging Undisputed 01/23/2026 1117553473 CMS
Amgen Inc. $3,500.00 05/22/2024 Consulting Fee Undisputed 01/23/2026 1117553471 CMS
Amgen Inc. $2,000.00 07/30/2024 Consulting Fee Undisputed 01/23/2026 1117251082 CMS
BioMarin Pharmaceutical Inc. $900.00 06/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1127062762 CMS
BioMarin Pharmaceutical Inc. $64.95 10/23/2024 Food and Beverage Undisputed 01/23/2026 1127059311 CMS
BioMarin Pharmaceutical Inc. $1,350.00 12/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1127059305 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $891.39 11/06/2024 Travel and Lodging Undisputed 01/23/2026 1117974199 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 12/11/2024 Food and Beverage Undisputed 01/23/2026 1117974189 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 12/11/2024 Travel and Lodging Undisputed 01/23/2026 1117974195 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $5,100.00 12/11/2024 Consulting Fee Undisputed 01/23/2026 1117974201 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.41 12/19/2024 Food and Beverage Undisputed 01/23/2026 1117974185 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.41 12/19/2024 Food and Beverage Undisputed 01/23/2026 1117974187 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $39.37 12/19/2024 Food and Beverage Undisputed 01/23/2026 1117974191 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $39.37 12/19/2024 Food and Beverage Undisputed 01/23/2026 1117974193 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $194.07 12/19/2024 Travel and Lodging Undisputed 01/23/2026 1117974197 CMS
Chiesi USA, Inc. $3,000.00 01/04/2024 Honoraria Undisputed 01/23/2026 1151806166 CMS
GENZYME CORPORATION $1,227.50 04/10/2024 Consulting Fee Undisputed 01/23/2026 1139986168 CMS
GENZYME CORPORATION $1,315.00 05/07/2024 Consulting Fee Undisputed 01/23/2026 1139986164 CMS
Gilead Sciences, Inc. $1,180.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1133600339 CMS
Incyte Corporation $2,227.50 06/06/2024 Consulting Fee Undisputed 01/23/2026 1141227966 CMS
Johnson & Johnson Health Care Systems Inc. $1,095.00 11/19/2024 Consulting Fee Undisputed 01/23/2026 1077572648 CMS
PFIZER INC. $1,350.00 12/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131234621 CMS
SANOFI PASTEUR INC. $1,578.00 06/26/2024 Consulting Fee Undisputed 01/23/2026 1128757853 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.